Ongoing multicenter trials in 2026 are evaluating novel hemorrhage control approaches, coordinated by international trauma research networks. These studies focus on diverse populations from North America to South Asia to establish evidence for broader implementation.

Novel hemostatic dressings comparison

Head-to-head trials compare chitosan, kaolin, and synthetic dressings in civilian trauma. Early results indicate faster hemostasis in coagulopathic subgroups.

Early vs delayed TXA in penetrating injury

Trials assess timing of tranexamic acid in stab and gunshot wounds. Data support prehospital use to maximize fibrinolytic inhibition benefits.

REBOA in non-compressible hemorrhage

Studies evaluate resuscitative endovascular balloon occlusion in blunt and penetrating torso trauma. Partial REBOA techniques show promise in preserving distal perfusion.

Combination therapies in obstetric bleeding

Trials combine mechanical, pharmacologic, and surgical interventions for severe postpartum hemorrhage. These aim to reduce hysterectomy rates in low-resource settings.

Trending news 2026: Trials unlocking next-level bleeding control

• Imaging detects hidden hemorrhage sites
• Inhibitors studied for neuroprotection in shock
• Antifungals reduce infection-related bleeding
• Microscopy guides precise hemostasis
• Infections complicate hemorrhage management
• Materials inspire biocompatible hemostatics
• Quality control ensures reliable clotting drugs
• Sequencing identifies bleeding risk genes
• Therapies explored for vascular repair
• Compounds prevent UTI-related bleeding

Thanks for Reading — Track trials shaping the future of hemorrhage control.